Grace Therapeutics Ownership | Who Owns Grace Therapeutics?
Grace Therapeutics Ownership Summary
Grace Therapeutics is owned by 19.55% institutional investors, 27.06% insiders, and 53.39% retail investors. Nantahala capital management is the largest institutional shareholder, holding 6.96% of GRCE shares.
GRCE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Grace Therapeutics | 19.55% | 27.06% | 53.39% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nantahala capital management | 1.18M | 6.96% | $4.08M |
| Aigh capital management | 907.22K | 5.70% | $3.15M |
| Vanguard group | 423.98K | 2.66% | $1.48M |
| Cerity partners | 422.73K | 2.65% | $1.46M |
| Adar1 capital management | 350.45K | 2.20% | $1.04M |
| Renaissance | 129.78K | 0.77% | $449.04K |
| Morgan stanley | 25.45K | 0.15% | $88.05K |
| Gsa capital partners llp | 13.77K | 0.09% | $48.00K |
| Stratos wealth partners | 11.18K | 0.07% | $38.69K |
| National bank of canada /fi/ | 2.72K | 0.02% | $8.04K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aigh capital management | 907.22K | 0.76% | $3.15M |
| Nantahala capital management | 1.18M | 0.13% | $4.08M |
| Adar1 capital management | 350.45K | 0.10% | $1.04M |
| Gsa capital partners llp | 13.77K | 0.00% | $48.00K |
| Cerity partners | 422.73K | 0.00% | $1.46M |
| Renaissance | 129.78K | 0.00% | $449.04K |
| Stratos wealth partners | 11.18K | 0.00% | $38.69K |
| Tower research capital llc (trc) | 1.61K | 0.00% | $4.79K |
| Activest wealth management | 104.00 | 0.00% | $360.00 |
| Steward partners investment advisory | 41.00 | - | $142.00 |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cerity partners | 422.73K | 0.00% | 422.73K |
| Adar1 capital management | 350.45K | 0.10% | 173.82K |
| Renaissance | 129.78K | 0.00% | 45.22K |
| Morgan stanley | 25.45K | - | 23.60K |
| Vanguard group | 423.98K | - | 14.88K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Stonepine capital management | - | - | -211.01K |
| Palumbo wealth management | - | - | -48.54K |
| Millington financial advisors | - | - | -20.00K |
| Seacrest wealth management | - | - | -14.00K |
| Citigroup | - | - | -2.76K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Cerity partners | 422.73K | 0.00% | 422.73K | $1.46M |
| Gsa capital partners llp | 13.77K | 0.00% | 13.77K | $48.00K |
| Stratos wealth partners | 11.18K | 0.00% | 11.18K | $38.69K |
| Bnp paribas arbitrage, snc | 600.00 | - | 600.00 | $2.08K |
| Flagship harbor advisors | 2.00 | - | 2.00 | $7.00 |
Sold Out
| Holder | Change |
|---|---|
| Jpmorgan chase | -15.00 |
| Jones financial companies lllp | -29.00 |
| Citigroup | -2.76K |
| Seacrest wealth management | -14.00K |
| Millington financial advisors | -20.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 15 | -25.00% | 3,113,169 | -16.00% | 19 | 3.61% | 8 | -11.11% | - | -100.00% |
| Sep 30, 2025 | 20 | 11.11% | 3,706,255 | -1.97% | 23 | 4.13% | 9 | 50.00% | 2 | -66.67% |
| Jun 30, 2025 | 20 | 17.65% | 3,816,908 | -5.15% | 23 | 1.96% | 6 | -25.00% | 7 | - |
| Mar 31, 2025 | 17 | 13.33% | 4,024,092 | 92.74% | 34 | 10.62% | 8 | -42.86% | 7 | 600.00% |
| Dec 31, 2024 | 15 | 1400.00% | 2,087,880 | 117.58% | 18 | 26.09% | 14 | 1300.00% | 1 | - |
GRCE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools